Rexahn Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Rexahn Pharmaceuticals's estimated annual revenue is currently $3.5M per year.
- Rexahn Pharmaceuticals's estimated revenue per employee is $500,000
- Rexahn Pharmaceuticals's total funding is $5M.
Employee Data
- Rexahn Pharmaceuticals has 7 Employees.
- Rexahn Pharmaceuticals grew their employee count by -12% last year.
Rexahn Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
Rexahn Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7M | 35 | -3% | N/A | N/A |
#2 | $7.2M | 36 | -5% | N/A | N/A |
#3 | $10.5M | 52 | -9% | N/A | N/A |
#4 | $344.1M | 1712 | 9% | N/A | N/A |
#5 | $27.5M | 137 | 6% | N/A | N/A |
#6 | $107.3M | 534 | 9% | N/A | N/A |
#7 | $12.9M | 64 | 28% | N/A | N/A |
#8 | $31.6M | 157 | 1% | N/A | N/A |
#9 | $31.4M | 156 | 7% | N/A | N/A |
#10 | $11.5M | 57 | 30% | N/A | N/A |
What Is Rexahn Pharmaceuticals?
Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of innovative treatments for cancer, central nervous system disorders and other unmet medical needs. Our motto is "Saving Lives Through Innovation," which represents the Company's use of scientific innovation to improve the health and wellness of patients. We develop therapies that treat specific disease states, while minimizing side effects in order to help patients regain quality of life during treatment.
keywords:N/A
$5M
Total Funding
7
Number of Employees
$3.5M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Rexahn Pharmaceuticals News
Rexahn Pharmaceuticals, Inc. ... Alnylam Pharmaceuticals, Inc. ... and increasing collaborations among pharmaceutical companies,...
Other Companies in Rockville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 7 | -36% | N/A |
#2 | N/A | 7 | -46% | N/A |
#3 | $1.1M | 7 | 0% | N/A |
#4 | $0.5M | 7 | 0% | N/A |
#5 | $0.5M | 7 | -36% | N/A |